19 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS : Nomination de Frédérique SCHMIDT en tant que Directrice Administrative et Financière du Groupe
|
10101015 Software |
Journal / appointments |
19 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS: Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer
|
10101015 Software |
Journal / appointments |
09 Nov 2022
18:00 CET |
EQUASENS |
GROUPE EQUASENS : Chiffre d’affaires du 3ème trimestre 2022
|
10101015 Software |
Sales |
09 Nov 2022
18:00 CET |
EQUASENS |
EQUASENS GROUP: 2022 third-quarter revenue
|
10101015 Software |
Sales |
18 Oct 2022
18:00 CEST |
EQUASENS |
EQUASENS: subsidiary PANDALAB receives ISO 27001 and HDS certifications
|
10101015 Software |
Corporate life |
18 Oct 2022
18:00 CEST |
EQUASENS |
EQUASENS : sa filiale PANDALAB certifié ISO 27001 et HDS
|
10101015 Software |
Corporate life |
30 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2022
|
10101015 Software |
Income |
22 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS : Résultats Semestriels 2022
|
10101015 Software |
Income |
22 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS: H1 2022 Results
|
10101015 Software |
Income |
03 Aug 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex-PHARMAGEST INTERACTIVE) : Chiffre d’affaires du 1er semestre 2022
|
10101015 Software |
Sales |
03 Aug 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue
|
10101015 Software |
Sales |
28 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex - PHARMAGEST INTERACTIVE) : Le Groupe complète 3 prises de participation majoritaire
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
28 Jul 2022
18:00 CEST |
EQUASENS |
Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
21 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT
|
10101015 Software |
Other subject |
21 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex PHARMAGEST INTERACTIVE) : BILAN SEMESTRIEL S1-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
|
10101015 Software |
Other subject |
06 Jul 2022
19:01 CEST |
EQUASENS |
EQUASENS (Ex Pharmagest Interactive): RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 28 JUNE 2022
|
10101015 Software |
General meeting / Board Meeting |
06 Jul 2022
19:01 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive) : RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 28 JUIN 2022
|
10101015 Software |
General meeting / Board Meeting |
27 Jun 2022
07:00 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive) joins Euronext’s new TECH LEADERS segment
|
10101015 Software |
Share history |
27 Jun 2022
07:00 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive) intègre le nouveau segment Euronext TECH LEADERS
|
10101015 Software |
Share history |
15 Jun 2022
18:30 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive): New ticker code
|
10101015 Software |
Share history |
15 Jun 2022
18:30 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive) : Nouveau code mnémonique
|
10101015 Software |
Share history |
15 Jun 2022
07:00 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive ) : nouvelle gamme de logiciel (HAD) triplement référencée SEGUR
|
10101015 Software |
New |
10 Jun 2022
19:17 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive): Annual General Meeting of June 28, 2022 - Notice of meeting - Availability of meeting materials
|
10101015 Software |
General meeting / Board Meeting |
10 Jun 2022
18:50 CEST |
EQUASENS |
EQUASENS (ex PHARMAGEST INTERACTIVE) : AGO du 28 juin 2022 - Avis de convocation - Modalités de mise à disposition des documents préparatoires
|
10101015 Software |
General meeting / Board Meeting |
03 Jun 2022
18:12 CEST |
PHARMAGEST INTER. |
EQUASENS (PHARMAGEST INTERACTIVE) : MédiStory 4, Premier logiciel médecin référencé Ségur !
|
10101015 Software |
New |
30 May 2022
18:11 CEST |
PHARMAGEST INTER. |
EQUASENS (PHARMAGEST INTERACTIVE) : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE AVIS PREALABLE DE REUNION
|
10101015 Software |
General meeting / Board Meeting |
30 May 2022
18:11 CEST |
PHARMAGEST INTER. |
EQUASENS (Pharmagest Interactive): ANNUAL ORDINARY GENERAL MEETING PRELIMINARY NOTICE
|
10101015 Software |
General meeting / Board Meeting |
12 May 2022
18:10 CEST |
PHARMAGEST INTER. |
EQUASENS (PHARMAGEST INTERACTIVE) : CA T1 2022 : +9,03% à 49,36 M€
|
10101015 Software |
Sales |
12 May 2022
18:10 CEST |
PHARMAGEST INTER. |
EQUASENS (Pharmagest Interactive): Q1 2022 revenue: +9.03% to €49.36m
|
10101015 Software |
Sales |
10 May 2022
07:01 CEST |
PHARMAGEST INTER. |
Pharmagest Interactive: RESULTS OF THE VOTE ON THE RESOLUTIONS SUBMITTED TO THE EXTRAORDINARY GENERAL MEETING OF 6 MAY 2022
|
10101015 Software |
General meeting / Board Meeting |
10 May 2022
07:01 CEST |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 6 MAI 2022
|
10101015 Software |
General meeting / Board Meeting |
02 May 2022
18:00 CEST |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : Modalités de mise à disposition du Document d’Enregistrement Universel 2021
|
10101015 Software |
Other subject |
28 Mar 2022
18:00 CEST |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : Le Groupe Pharmagest change de nom et deviendra le Groupe EQUASENS
|
10101015 Software |
Corporate life |
25 Mar 2022
19:20 CET |
PHARMAGEST INTER. |
Pharmagest Interactive: 2021 Net Profit: +25.97% to €41.15m and new name proposal for the Group
|
10101015 Software |
Income |
25 Mar 2022
19:20 CET |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : Résultat Net 2021 : +25,97% à 41,15 M€ et projet de changement de nom
|
10101015 Software |
Income |
04 Feb 2022
18:04 CET |
PHARMAGEST INTER. |
Pharmagest Interactive: 2021 revenue: €193.07m, up 12.41%
|
10101015 Software |
Sales |
04 Feb 2022
18:04 CET |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : CA 2021 : +12,41% à 193,07 M€
|
10101015 Software |
Sales |
27 Jan 2022
07:53 CET |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : Bilan semestriel S2 2021 du contrat de liquidité
|
10101015 Software |
Other subject |
03 Dec 2021
18:00 CET |
PHARMAGEST INTER. |
Pharmagest Interactive: New executive management team
|
10101015 Software |
Journal / appointments |
03 Dec 2021
18:00 CET |
PHARMAGEST INTER. |
PHARMAGEST INTERACTIVE : Nouvelle direction générale
|
10101015 Software |
Journal / appointments |